Longevity and determinants of protective humoral immunity after pandemic influenza infection.
about
Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infectionCytomegalovirus serostatus, inflammation, and antibody response to influenza vaccination in older adults: The moderating effect of beta blockade.Immunity to influenza. Preventing infection and regulating disease.Influenza A(H7N9) Virus Antibody Responses in Survivors 1 Year after Infection, China, 2017.Prolonged Evolution of Virus-Specific Memory T Cell Immunity after Severe Avian Influenza A (H7N9) Virus Infection
P2860
Longevity and determinants of protective humoral immunity after pandemic influenza infection.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Longevity and determinants of ...... pandemic influenza infection.
@ast
Longevity and determinants of ...... pandemic influenza infection.
@en
type
label
Longevity and determinants of ...... pandemic influenza infection.
@ast
Longevity and determinants of ...... pandemic influenza infection.
@en
prefLabel
Longevity and determinants of ...... pandemic influenza infection.
@ast
Longevity and determinants of ...... pandemic influenza infection.
@en
P2093
P2860
P1476
Longevity and determinants of ...... pandemic influenza infection.
@en
P2093
Alison Bermingham
Katja Hoschler
Shaima Begom
Steven Riley
Walt Adamson
William Carman
P2860
P304
P356
10.1164/RCCM.201410-1798OC
P407
P577
2015-02-01T00:00:00Z